Total Payments
$5,151
2024 Payments
$490.65
Companies
31
Transactions
269
Medicare Patients
8,487
Medicare Billing
$664,476
Payment Breakdown by Category
Food & Beverage$5,151 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,151 | 269 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $839.39 | 37 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $539.93 | 25 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $518.35 | 35 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $402.26 | 28 | $0 (2023) |
| Merck Sharp & Dohme LLC | $279.40 | 18 | $0 (2023) |
| Amgen Inc. | $263.88 | 15 | $0 (2024) |
| Inari Medical, Inc. | $252.16 | 1 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $246.65 | 15 | $0 (2024) |
| Boston Scientific Corporation | $238.08 | 9 | $0 (2023) |
| PFIZER INC. | $236.69 | 16 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $490.65 | 25 | SCPHARMACEUTICALS INC. ($80.53) |
| 2023 | $1,432 | 61 | Janssen Pharmaceuticals, Inc ($356.96) |
| 2022 | $1,082 | 56 | Inari Medical, Inc. ($252.16) |
| 2021 | $908.48 | 61 | Janssen Pharmaceuticals, Inc ($161.99) |
| 2020 | $434.02 | 29 | Medtronic Vascular, Inc. ($84.16) |
| 2019 | $611.01 | 34 | Janssen Pharmaceuticals, Inc ($175.57) |
| 2017 | $192.31 | 3 | Boehringer Ingelheim Pharmaceuticals, Inc. ($112.35) |
All Payment Transactions
269 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/27/2024 | Medtronic, Inc. | TYRX (Device) | Food and Beverage | In-kind items and services | $20.79 | General |
| Category: Antibacterial Mesh | ||||||
| 09/26/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $22.14 | General |
| Category: Cardiology | ||||||
| 09/12/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $14.80 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/09/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $18.40 | General |
| Category: Cardiovascular | ||||||
| 07/18/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $13.97 | General |
| Category: Cardiovascular | ||||||
| 06/18/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $23.18 | General |
| Category: Cardiology | ||||||
| 06/17/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/05/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $21.98 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/23/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.07 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/22/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $13.71 | General |
| Category: Cardiology | ||||||
| 05/20/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.48 | General |
| Category: DIABETES | ||||||
| 05/01/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $23.64 | General |
| Category: Not Applicable | ||||||
| 04/26/2024 | Medtronic, Inc. | AZURE XT DR MRI SURESCAN (Device) | Food and Beverage | In-kind items and services | $38.59 | General |
| Category: Pacemakers | ||||||
| 03/27/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $14.65 | General |
| Category: Cardiology | ||||||
| 03/18/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $19.75 | General |
| Category: Cardiology | ||||||
| 03/14/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $23.45 | General |
| Category: DIABETES | ||||||
| 03/13/2024 | BIOTRONIK INC. | BIOMONITOR (Device), AMVIA EDGE | Food and Beverage | In-kind items and services | $23.37 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/12/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $16.64 | General |
| Category: Diabetes | ||||||
| 02/15/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $13.63 | General |
| Category: Not Applicable | ||||||
| 02/12/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.50 | General |
| Category: DIABETES | ||||||
| 01/31/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.08 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/24/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $15.46 | General |
| Category: Cardiology | ||||||
| 01/23/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $31.06 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 01/17/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $19.94 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 01/05/2024 | Abbott Laboratories | JOT DX (Device) | Food and Beverage | In-kind items and services | $16.02 | General |
| Category: Cardiac Rhythm Management | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 2,155 | 2,853 | $561,274 | $177,771 |
| 2022 | 29 | 2,261 | 2,966 | $562,036 | $180,732 |
| 2021 | 26 | 1,948 | 2,513 | $426,527 | $157,335 |
| 2020 | 23 | 2,123 | 2,584 | $389,280 | $148,638 |
Total Patients
8,487
Total Services
10,916
Medicare Billing
$664,476
Procedure Codes
117
All Medicare Procedures & Services
117 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 242 | 434 | $86,800 | $38,071 | 43.9% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 77 | 153 | $105,008 | $24,050 | 22.9% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 176 | 287 | $71,742 | $18,289 | 25.5% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 343 | 349 | $69,800 | $17,829 | 25.5% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 76 | 151 | $29,040 | $13,053 | 44.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 107 | 107 | $32,100 | $11,686 | 36.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 102 | 172 | $18,920 | $10,286 | 54.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 103 | 104 | $15,600 | $9,932 | 63.7% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 41 | 164 | $15,000 | $7,517 | 50.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 119 | 129 | $15,480 | $7,435 | 48.0% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 53 | 53 | $15,900 | $2,963 | 18.6% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 88 | 92 | $10,000 | $2,834 | 28.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 20 | 21 | $6,300 | $2,817 | 44.7% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 59 | 59 | $16,520 | $2,740 | 16.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 238 | 266 | $17,290 | $2,689 | 15.6% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 53 | 53 | $4,240 | $832.52 | 19.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 11 | 11 | $2,200 | $782.92 | 35.6% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 44 | 44 | $3,300 | $772.03 | 23.4% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 54 | 54 | $10,800 | $566.26 | 5.2% |
| 93017 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) | Office | 2023 | 27 | 27 | $4,239 | $540.63 | 12.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 11 | 12 | $1,440 | $532.40 | 37.0% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Office | 2023 | 27 | 27 | $2,160 | $432.27 | 20.0% |
| 93244 | Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 24 | 24 | $960.00 | $414.07 | 43.1% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Office | 2023 | 27 | 27 | $5,400 | $285.66 | 5.3% |
| 93228 | Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | Office | 2023 | 14 | 14 | $560.00 | $256.83 | 45.9% |
About Dr. Sofy Landes, MD
Dr. Sofy Landes, MD is a Cardiovascular Disease healthcare provider based in Ladson, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/30/2012. The National Provider Identifier (NPI) number assigned to this provider is 1265790133.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sofy Landes, MD has received a total of $5,151 in payments from pharmaceutical and medical device companies, with $490.65 received in 2024. These payments were reported across 269 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($5,151).
As a Medicare-enrolled provider, Landes has provided services to 8,487 Medicare beneficiaries, totaling 10,916 services with total Medicare billing of $664,476. Data is available for 4 years (2020–2023), covering 117 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Ladson, SC
- Active Since 04/30/2012
- Last Updated 10/14/2024
- Taxonomy Code 207RC0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1265790133
Products in Payments
- XARELTO (Drug) $839.39
- ELIQUIS (Drug) $617.59
- JARDIANCE (Drug) $412.46
- VERQUVO (Drug) $279.40
- FLOWTRIEVER CATHETER, S (Device) $252.16
- FARXIGA (Drug) $217.05
- Repatha (Biological) $167.40
- ENTRESTO (Drug) $165.26
- BRILINTA (Drug) $132.18
- AZURE XT DR MRI SURESCAN (Device) $97.20
- Corlanor (Drug) $96.48
- ZIO XT Patch (Device) $88.57
- ONPATTRO (Drug) $83.65
- Reveal LINQ (Device) $83.53
- Arcalyst (Drug) $82.72
- LEQVIO (Drug) $81.39
- FUROSCIX (Drug) $80.53
- MULTAQ (Drug) $78.91
- (5044) MCOT (Device) $73.34
- VYNDAQEL (Drug) $70.67
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Ladson
Mr. Frederick Funke, Md, MD
Cardiovascular Disease — Payments: $19,511
Cardiovascular Disease $19,511
Dr. Jason Coker, M.d, M.D
Cardiovascular Disease — Payments: $17,792
Cardiovascular Disease $17,792
Christopher Mccarty, M.d, M.D
Cardiovascular Disease — Payments: $16,917
Cardiovascular Disease $16,917
Dr. Mark Mataosky, M.d, M.D
Cardiovascular Disease — Payments: $7,114
Cardiovascular Disease $7,114
Mark Coker, M.d, M.D
Cardiovascular Disease — Payments: $7,093
Cardiovascular Disease $7,093
Chris Kennedy, M.d, M.D
Cardiovascular Disease — Payments: $6,391
Cardiovascular Disease $6,391